IBM and the American Cancer Society (ACS)
are teaming up to create the first virtual cancer health advisor for
people fighting cancer, powered by IBM Watson. The initiative aims to
provide cancer patients, survivors, and caregivers with trusted ACS
resources and guidance personalized to an individual’s unique journey
against cancer. Once developed, the advisor will anticipate the needs of people with
different types of cancers, at different stages of disease, and at
various points in treatment. It will be dynamic and become increasingly
personalized as individuals engage with it, effectively getting
“smarter” each time it is used. ACS and IBM also plans to
integrate Watson’s voice recognition and natural language processing
technology, enabling users to ask questions and receive audible
responses. ACS and IBM has long term plans to integrate the advisor with IBM’s existing Watson for Oncology offering
for doctors. Watson for Oncology is a clinical decision support tool
that helps doctors make personalized, evidence-based treatment decisions
for their patients. By integrating the ACS advisor, clinicians could be
prompted to share personalized guidance on resources, including
educational materials and social services and programs such as ACS’s
Road to Recovery transportation, Hope Lodge housing, and Look Good Feel
Better.
IBM is currently working with researchers, clinicians, and cancer
institutions to apply Watson technology to the data challenges of cancer
treatment through partnerships with Memorial Sloan-Kettering Cancer Center and MD Anderson Cancer Center. At Mayo Clinic, Watson is helping doctors match patients to relevant clinical trials, and 16 leading cancer institutes are working with Watson to help doctors translate DNA insights into personalized treatment options for patients.
No comments:
Post a Comment